LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,200,000 | -4.8% | 21,653 | -4.4% | 0.00% | 0.0% |
| Q3 2016 | $2,312,000 | -48.5% | 22,650 | -39.8% | 0.00% | -60.0% |
| Q2 2016 | $4,488,000 | +14.8% | 37,627 | +3.0% | 0.01% | +25.0% |
| Q1 2016 | $3,910,000 | -1.4% | 36,516 | -0.2% | 0.00% | 0.0% |
| Q4 2015 | $3,967,000 | +7.2% | 36,592 | -15.3% | 0.00% | 0.0% |
| Q3 2015 | $3,700,000 | -18.5% | 43,199 | -4.0% | 0.00% | -20.0% |
| Q2 2015 | $4,541,000 | -6.7% | 45,007 | -28.7% | 0.01% | 0.0% |
| Q1 2015 | $4,868,000 | +26.5% | 63,130 | -12.7% | 0.01% | +25.0% |
| Q4 2014 | $3,847,000 | +16.8% | 72,300 | +3.1% | 0.00% | +33.3% |
| Q3 2014 | $3,294,000 | -24.7% | 70,095 | -0.2% | 0.00% | -25.0% |
| Q2 2014 | $4,374,000 | +104.3% | 70,213 | +120.6% | 0.00% | +100.0% |
| Q1 2014 | $2,141,000 | +158.9% | 31,830 | +102.6% | 0.00% | +100.0% |
| Q4 2013 | $827,000 | +33.2% | 15,714 | +9.5% | 0.00% | 0.0% |
| Q3 2013 | $621,000 | -46.5% | 14,350 | -53.7% | 0.00% | 0.0% |
| Q2 2013 | $1,160,000 | – | 31,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |